Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfeffer

Showing results (131-140 of 188) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|March 16, 1995
A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart diseaseK Lindpaintner, M A Pfeffer, R Kreutz, et al.
Hypertension (Dallas, Tex. : 1979)|December 26, 2001
Pulsatile hemodynamics in congestive heart failureG F Mitchell, J C Tardif, J M Arnold, et al.
The American Journal of Cardiology|September 8, 2001
The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarctionP F Bray, C P Cannon, P Goldschmidt-Clermont, et al.
Clinical Cardiology|May 1, 1992
The effect of treatment on survival in congestive heart failureB Pitt, J N Cohn, G S Francis, et al.
Circulation|October 18, 2000
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trialF M Sacks, P Alaupovic, L A Moye, et al.
Circulation|September 17, 1998
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) InvestigatorsP M Ridker, N Rifai, M A Pfeffer, et al.
Journal of Cardiac Failure|September 25, 1999
Inducible nitric oxide synthase and tumor necrosis factor in animal models of myocardial necrosis induced by coronary artery ligation or isoproterenol injectionS A Grosjean, M A Arstall, R N Mitchell, et al.
Journal of the American College of Cardiology|October 1, 1995
Cost-effectiveness of captopril therapy after myocardial infarctionJ Tsevat, D Duke, L Goldman, et al.
The American Journal of Cardiology|December 1, 1991
Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE)F M Sacks, M A Pfeffer, L Moye', et al.
Journal of the American College of Cardiology|February 6, 1999
Ejection fraction by radionuclide ventriculography and contrast left ventriculogram. A tale of two techniques. SAVE Investigators. Survival and Ventricular EnlargementP E Ureña, G A Lamas, G Mitchell, et al.
Pageof 19

Showing results (131-140 of 188) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|March 16, 1995
A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart diseaseK Lindpaintner, M A Pfeffer, R Kreutz, et al.
Hypertension (Dallas, Tex. : 1979)|December 26, 2001
Pulsatile hemodynamics in congestive heart failureG F Mitchell, J C Tardif, J M Arnold, et al.
The American Journal of Cardiology|September 8, 2001
The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarctionP F Bray, C P Cannon, P Goldschmidt-Clermont, et al.
Clinical Cardiology|May 1, 1992
The effect of treatment on survival in congestive heart failureB Pitt, J N Cohn, G S Francis, et al.
Circulation|October 18, 2000
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trialF M Sacks, P Alaupovic, L A Moye, et al.
Circulation|September 17, 1998
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) InvestigatorsP M Ridker, N Rifai, M A Pfeffer, et al.
Journal of Cardiac Failure|September 25, 1999
Inducible nitric oxide synthase and tumor necrosis factor in animal models of myocardial necrosis induced by coronary artery ligation or isoproterenol injectionS A Grosjean, M A Arstall, R N Mitchell, et al.
Journal of the American College of Cardiology|October 1, 1995
Cost-effectiveness of captopril therapy after myocardial infarctionJ Tsevat, D Duke, L Goldman, et al.
The American Journal of Cardiology|December 1, 1991
Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE)F M Sacks, M A Pfeffer, L Moye', et al.
Journal of the American College of Cardiology|February 6, 1999
Ejection fraction by radionuclide ventriculography and contrast left ventriculogram. A tale of two techniques. SAVE Investigators. Survival and Ventricular EnlargementP E Ureña, G A Lamas, G Mitchell, et al.
Pageof 19